CORTINOVIS, DIEGO LUIGI
CORTINOVIS, DIEGO LUIGI
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries
2024 Reguart, N; Pérol, M; Cortinovis, D; Puntis, S; Öhrling, K; Archangelidi, O; Louie, K; Blackhall, F; Sebastian, M
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)
2024 Pizzutilo, E; Agostara, A; Oresti, S; Signorelli, D; Stabile, S; Lauricella, C; Motta, V; Amatu, A; Ruggieri, L; Brambilla, M; Occhipinti, M; Proto, C; Giusti, R; Filetti, M; Genova, C; Barletta, G; Gelsomino, F; Bennati, C; Siringo, M; Di Fazio, G; Russano, M; Montrone, M; Gariazzo, E; Roca, E; Bordi, P; Delmonte, A; Scimone, A; Belluomini, L; Mazzoni, F; Carta, A; Pelizzari, G; Viscardi, G; Morgillo, F; Gelibter, A; Gori, S; Berardi, R; Cortinovis, D; Ardizzoni, A; Veronese, S; Sartore-Bianchi, A; Giannetta, L; Cerea, G; Siena, S
Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future Challenges
2024 Cortinovis, D; Leonetti, A; Morabito, A; Sala, L; Tiseo, M
Colorectal Cancer Pulmonary Metastasectomy: When, Why and How
2024 Petrella, F; Danuzzo, F; Sibilia, M; Vaquer, S; Longarini, R; Guidi, A; Raveglia, F; Libretti, L; Pirondini, E; Cara, A; Cassina, E; Tuoro, A; Cortinovis, D
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting
2024 Seminati, D; L'Imperio, V; Casati, G; Ceku, J; Pilla, D; Scalia, C; Gragnano, G; Pepe, F; Pisapia, P; Sala, L; Cortinovis, D; Bono, F; Malapelle, U; Troncone, G; Novello, S; Pagni, F
Emerging Treatment Options for Neuroendocrine Neoplasms of Unknown Primary Origin: Current Evidence and Future Perspectives
2024 Corti, F; Rossi, R; Cafaro, P; Passarella, G; Turla, A; Pusceddu, S; Coppa, J; Oldani, S; Guidi, A; Longarini, R; Cortinovis, D
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database
2024 Reale, M; Passiglia, F; Cappuzzo, F; Minuti, G; Occhipinti, M; Bulotta, A; Delmonte, A; Sini, C; Galetta, D; Roca, E; Pelizzari, G; Cortinovis, D; Gariazzo, E; Pilotto, S; Citarella, F; Bria, E; Muscolino, P; Pozzessere, D; Carta, A; Pignataro, D; Calvetti, L; Leone, F; Banini, M; Di Micco, C; Baldini, E; Favaretto, A; Malapelle, U; Novello, S; Pasello, G; Tiseo, M
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
2024 Villa, M; Malighetti, F; Sala, E; Sharma, G; Arosio, G; Gemelli, M; Manfroni, C; Fontana, D; Cordani, N; Meneveri, R; Zambon, A; Piazza, R; Pagni, F; Cortinovis, D; Mologni, L
Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesothelioma
2024 Pellicioli, F; Sala, L; Colonese, F; Belloni, E; Abbate, M; Canova, S; D'Agostino, A; Cortinovis, D
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
2024 Szlosarek, P; Creelan, B; Sarkodie, T; Nolan, L; Taylor, P; Olevsky, O; Grosso, F; Cortinovis, D; Chitnis, M; Roy, A; Gilligan, D; Kindler, H; Papadatos-Pastos, D; Ceresoli, G; Mansfield, A; Tsao, A; O’Byrne, K; Nowak, A; Steele, J; Sheaff, M; Shiu, C; Kuo, C; Johnston, A; Bomalaski, J; Zauderer, M; Fennell, D; Rybkin, I; Rolfo, C; Mackean, M; Steele, N; Franks, K; Shaw, P; Lind, M; Upadhyay, S; John, T; Karapetis, C; Srivastav, R; Mencoboni, M; Chella, A; Zilembo, N; de Marinis, F; Stella, M; Chong, I; Wang, C; Null, N
Pleural mesothelioma in situ: A comprehensive review
2024 Danuzzo, F; Raveglia, F; Spinelli, F; Sibilia, C; Cassina, E; Libretti, L; Pirondini, E; Tuoro, A; Bono, F; Paladino, M; Cortinovis, D; Petrella, F
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer
2024 Cordani, N; Nova, D; Sala, L; Abbate, M; Colonese, F; Cortinovis, D; Canova, S
RAC1 as a potential pan-cancer diagnostic, prognostic, and immunological biomarker
2024 Tao, L; Xu, X; Fang, Z; Christopoulos, P; Cortinovis, D; Lu, Y
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
2024 Leonetti, A; Perrone, F; Puntoni, M; Maglietta, G; Bordi, P; Bria, E; Vita, E; Gelsomino, F; De Giglio, A; Gelibter, A; Siringo, M; Mazzoni, F; Caliman, E; Genova, C; Bertolini, F; Guaitoli, G; Passiglia, F; Delcuratolo, M; Montrone, M; Cerea, G; Pasello, G; Roca, E; Belluomini, L; Cecere, F; Guida, A; Manzo, A; Adamo, V; Rastelli, F; Bulotta, A; Citarella, F; Toschi, L; Zoratto, F; Cortinovis, D; Berardi, R; Follador, A; Carta, A; Camerini, A; Salerno, F; Silva, R; Baldini, E; Cortellini, A; Brighenti, M; Santoni, M; Malorgio, F; Caminiti, C; Tiseo, M
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
2024 Passiglia, F; Lucia Reale, M; Lo Russo, G; Pasello, G; Minuti, G; Bulotta, A; Galetta, D; Pelizzari, G; Sini, C; Bria, E; Roca, E; Pilotto, S; Genova, C; Metro, G; Citarella, F; Chiari, R; Cortinovis, D; Delmonte, A; Russo, A; Tiseo, M; Cerea, G; Carta, A; Scotti, V; Vavalà, T; Brambilla, M; Buffoni, L; Buosi, R; Catania, C; Gori, S; Grisanti, S; Agustoni, F; Garbo, E; Malapelle, U; Novello, S
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database
2024 Malapelle, U; Passiglia, F; Pepe, F; Pisapia, P; Lucia Reale, M; Cortinovis, D; Fraggetta, F; Galetta, D; Garbo, E; Graziano, P; Pagni, F; Pasello, G; Piovano, P; Pilotto, S; Tiseo, M; Genova, C; Righi, L; Troncone, G; Novello, S
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective
2023 Cordani, N; Bianchi, T; Ammoni, L; Cortinovis, D; Cazzaniga, M; Lissoni, A; Landoni, F; Canova, S
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
2023 Lee, S; Schulz, C; Prabhash, K; Kowalski, D; Szczesna, A; Han, B; Rittmeyer, A; Talbot, T; Vicente, D; Califano, R; Cortinovis, D; Le, A; Huang, D; Liu, G; Cappuzzo, F; Contreras, J; Reck, M; Palmero, R; Mak, M; Hu, Y; Morris, S; Höglander, E; Connors, M; Biggane, A; Vollan, H; Peters, S
Novel Therapeutic Options for Small Cell Lung Cancer
2023 Canova, S; Trevisan, B; Abbate, M; Colonese, F; Sala, L; Baggi, A; Bianchi, S; D'Agostino, A; Cortinovis, D
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
2023 Heymach, J; Harpole, D; Mitsudomi, T; Taube, J; Galffy, G; Hochmair, M; Winder, T; Zukov, R; Garbaos, G; Gao, S; Kuroda, H; Ostoros, G; Tran, T; You, J; Lee, K; Antonuzzo, L; Papai-Szekely, Z; Akamatsu, H; Biswas, B; Spira, A; Crawford, J; Le, H; Aperghis, M; Doherty, G; Mann, H; Fouad, T; Reck, M; Cortinovis, D